# Serina Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jul 22, 2026

- Company: [Serina Therapeutics, Inc.](/companies/ser.md) (CIK 1708599)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-22
- Accepted by EDGAR: Jul 22, 2026, 12:12 ET
- Period: not reported
- Accession: 0001104659-26-085696
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1708599/000110465926085696/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708599/000110465926085696/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708599/000110465926085696/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-085696. Last ingested by Listed: Nov 3, 2026, 18:22 ET. No prices; not investment advice.